Skip to main content

Corona in India - How Do Serology Tests Work for COVID-19 || Corona Cases

 Many people have been calling for more antibody tests for the novel coronavirus. And antibody tests certainly are important but it’s essential to understand a bit more about how these tests work and how the results will be used. So antibody tests are a type of test called a “serological” test and they detect the presence of antibody proteins made by our immune systems to fight infections like the one caused by the novel coronavirus.

But it can take many days after infection for our immune system to make antibodies that can become detectable by lab tests. That means that antibody tests aren’t very useful in identifying people who have recently become ill with the virus. Serological antibody tests are best used many days or even weeks after someone has had the infection. So serological test results give us information about who may have had the infection in the past. Right now, we don’t know if having antibodies to the novel coronavirus means that a person can’t get re-infected. Now we will know the answer to that important question eventually but until we do, how should antibody test results be used?

Well, one way to use them is to identify who has already had the infection but that’s more important from a population health perspective than from an individual patient perspective. Another way to use the test is to identify people who have recovered and who may be able to donate blood that can be given to critically sick people who are fighting the infection. When these really sick patients get blood from people who have already recovered, they may recover sooner or have an improvement in their symptoms. And we can also use antibody tests to help researchers develop new drugs to fight the infection. What all of this means is that antibody testing is critical to the ongoing research and fighting of the virus.

Using these tests though will require cooperation among lab scientists, researchers, doctors, and even governments as we all search for ways to manage this pandemic. 

Comments

Popular posts from this blog

More than 150 countries engaged in COVID-19 vaccine global access facility

* Seventy-five countries submit expressions of interest to COVAX Facility, joining up to 90 further countries which could be supported by the COVAX Advance Market Commitment (AMC) * The COVAX Facility, and the AMC within it, is designed to guarantee rapid, fair and equitable access to COVID-19 vaccines for every country in the world, rich and poor, to make rapid progress towards slowing the pandemic  * Interest from governments representing more than 60% of the world’s population offers ‘tremendous vote of confidence’ in the effort to ensure truly global access to COVID-19 vaccines, once developed Geneva/London, 15 July 2020 – Seventy-five countries have submitted expressions of interest to protect their populations and those of other nations through joining the COVAX Facility, a mechanism designed to guarantee rapid, fair and equitable access to COVID-19 vaccines worldwide. The 75 countries, which would finance the vaccines from their own public finance budgets, partner with up...